Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours: A Taiwanese Gynecologic Oncology Group study

European Journal of Cancer

Volumn 50, Issue 18, 2014, Pages 3161-3167

  Chen, Chi An ^a   Lin, Hao ^b   Weng, Chia Sui ^c   Wen, Kuo Chang ^d,e   Lu, Chien Hsing ^f   Chou, Hung Hsueh ^g   Huang, Yu Fang ^h   Kang, Chieh Yi ⁱ   Ho, Chih Ming ^j,k   Yu, Mu Hsien ^l   Chou, Cheng Yang ^h  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^g CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^h NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

ⁱ CHI MEI MEDICAL CENTER   (Taiwan)

^j CATHAY GENERAL HOSPITAL   (Taiwan)

^k FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^l TRI SERVICE GENERAL HOSPITAL   (Taiwan)

more..

Author keywords

BEP regimen; Chemotherapy; Fertility sparing surgery; Malignant germ cell tumours; Outcome

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; ARTICLE; BONE MARROW SUPPRESSION; BRONCHOSPASM; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CARCINOID; CHORIOCARCINOMA; DISEASE SEVERITY; DRUG EFFICACY; DRUG FEVER; DYSGERMINOMA; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GERM CELL TUMOR; HUMAN; ILEUS; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALIGNANT OVARIAN GERM CELL TUMOR; MALIGNANT TERATOMA; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUTROPENIA; ONSET AGE; OTOTOXICITY; OVARY CANCER; OVARY TERATOMA; PANCYTOPENIA; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; RAYNAUD PHENOMENON; SEIZURE; SLEEP DISORDER; TAIWANESE; TREATMENT DURATION; TREATMENT OUTCOME; URINARY TRACT INFECTION; YOLK SAC TUMOR; AGED; CLINICAL TRIAL; CONSERVATIVE TREATMENT; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GERM CELL AND EMBRYONAL; ORGAN SPARING TREATMENTS; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84925227182     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.10.006     Document Type: Article

References (22)

1. R.E. Slayton, R.C. Park, and S.C. Silverberg Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary: a Gynecologic Oncology Group Study (a final report) Cancer 56 1985 243 248
2. D.M. Gershenson, L.J. Copeland, and J.J. Kavanagh Treatment of malignant non-dysgerminomatous germ cell tumors of the ovary with vincristine, actinomycin-D, and cyclophosphamide Cancer 56 1985 2756 2761
3. L.H. Einhorn, and J. Donohue Cis-diamminedichloroplatinum, vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer Ann Intern Med 87 1977 293 298
4. S.D. Williams, J.A. Blessing, and D.H. Moore Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors Ann Intern Med 111 1989 22 27
5. D.M. Gershenson, M. Morris, and A. Cangir Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide and cisplatin J Clin Oncol 8 1990 715 720
6. S. Williams, J.A. Blessing, and S.Y. Liao Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide and bleomycin: a trial of the Gynecologic Oncology Group J Clin Oncol 12 1994 701 706
7. NCCN (National Comprehensive Cancer Network). Clinical practice guidelines in oncology (http://www.nccn.org/default.aspx).
8. E. Segelov, J. Campbell, and M. Ng Cisplatin-based chemotherapy for ovarian germ cell malignancies: the Australian experience J Clin Oncol 12 1994 378 384
9. WHO Pathology and genetics of tumours of the breast and female genital tract 2003 WHO, IARC Press Lyon
10. International Federation of Gynecology and Obstetrics Changes in definitions of clinical staging for carcinoma of the cervix and ovary: International Federation of Gynecology and Obstetrics Am J Obstet Gynecol 156 1987 263 264
11. D.M. O'Conner, and H.J. Norris The influence of grade on the outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading Int J Gynecol Pathol 13 1994 283 289
12. H. Kang, T.J. Kim, and W.Y. Kim Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor Gynecol Oncol 111 2008 106 110
13. S.K. Tay, and L.K. Tan Experience of a 2-day BEP regimen in postsurgical adjuvant chemotherapy of ovarian germ cell tumors Int J Gynecol Cancer 10 2000 13 18
14. P.L. Mitchell, N. Al-Nasiri, and R. A'Hern Treatment of nondysgerminomatous ovarian germ cell tumors Cancer 85 1999 2232 2244
15. M.A. Dimopoulos, C. Papadimitriou, and G. Hamilos Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study Gynecol Oncol 95 2004 695 700
16. T. de La Motte Rouge, P. Pautier, and P. Duvillard Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor Ann Oncol 19 2008 1435 1441
17. D.M. Gershenson Management of ovarian germ cell tumors J Clin Oncol 25 2007 2938 2943
18. O. Solheim, J. Kærn, and C.G. Tropé Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009) Gynecol Oncol 131 2013 330 335
19. O. Solheim, D.M. Gershenson, and C.G. Tropé Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010) Eur J Cancer 50 2014 1942 1950
20. D. Pectasides, E. Pectasides, and D. Kassanos Germ cell tumors of the ovary Cancer Treat Rev 34 2008 427 441
21. H. Sagstuen, N. Aass, and S.D. Fossa Blood pressure and body mass index in long-term survivors of testicular cancer J Clin Oncol 23 2005 4980 4990
22. L.B. Travis, C. Beard, and J.M. Allan Testicular cancer survivorship: Research strategies and recommendations J Natl Cancer Inst 102 2010 1114 1130